Etoricoxib Dosing for Osteoarthritis, Rheumatoid Arthritis, and Acute Gouty Arthritis
For osteoarthritis, use etoricoxib 60 mg once daily; for rheumatoid arthritis, use 90 mg once daily; and for acute gouty arthritis, use 120 mg once daily. 1, 2, 3
Specific Dosing by Indication
Osteoarthritis
- Etoricoxib 60 mg once daily is the recommended dose for chronic treatment of osteoarthritis 1, 3, 4
- This dose provides sustained efficacy comparable to naproxen 500 mg twice daily over long-term treatment (up to 138 weeks) 4
- However, NICE guidelines specifically recommend against using etoricoxib 60 mg as first-choice COX-2 inhibitor for osteoarthritis, suggesting other COX-2 inhibitors or standard NSAIDs instead 5
Rheumatoid Arthritis
- Etoricoxib 90 mg once daily is the recommended dose for chronic treatment of rheumatoid arthritis 1, 3, 6
- This dose demonstrates sustained efficacy over 121 weeks of treatment, with effectiveness comparable to naproxen 500 mg twice daily 6
- The 90 mg dose provides rapid and sustained improvements in disease activity, tender/swollen joint counts, and patient assessment measures 6
Acute Gouty Arthritis
- Etoricoxib 120 mg once daily is the recommended dose for acute gout flares 1, 2, 3
- This is the highest approved daily dose and is specifically indicated for acute pain relief in gouty arthritis 1
- The American College of Rheumatology guidelines support the use of COX-2 inhibitors like etoricoxib at full anti-inflammatory doses for acute gout, though etoricoxib is not available in the United States 5
- Treatment should be initiated within 24 hours of symptom onset for optimal outcomes 7, 8
Critical Prescribing Principles
Duration and Dosing Strategy
- Use the lowest effective dose for the shortest possible duration to minimize gastrointestinal, hepatic, and cardiorenal toxicity 5
- The long plasma half-life of etoricoxib allows for convenient once-daily dosing 1
- For acute gouty arthritis, continue treatment until complete resolution of symptoms, typically 5-14 days 7
Gastrointestinal Protection
- Always co-prescribe a proton pump inhibitor when using etoricoxib, selecting the one with the lowest acquisition cost 5
- Etoricoxib demonstrates fewer uncomplicated upper gastrointestinal adverse events compared to nonselective NSAIDs 2
Cardiovascular Risk Assessment
- Carefully assess cardiovascular risk factors before prescribing, including uncontrolled hypertension 2
- Etoricoxib was noninferior to diclofenac in terms of thrombotic cardiovascular events, but all NSAIDs carry CV risk 2
- Weigh potential GI and CV risks against benefits in each individual patient 2
Common Pitfalls to Avoid
- Do not use etoricoxib 60 mg as the first-choice COX-2 inhibitor for osteoarthritis per NICE guidance; consider other COX-2 inhibitors or standard NSAIDs first 5
- Do not exceed recommended doses: 60 mg for OA, 90 mg for RA, 120 mg for acute gout 1, 3
- Do not prescribe without assessing age and comorbidities, particularly in elderly patients who require careful risk-benefit assessment 5
- Do not forget to continue urate-lowering therapy during an acute gout attack if the patient is already on it 7, 8